Comer seeks details on PBM use of foreign group purchasing organizations

U.S. Rep. James Comer - Official U.S. House headshot
U.S. Rep. James Comer - Official U.S. House headshot
0Comments

House Committee on Oversight and Government Reform Chairman James Comer (R-Ky.) has expanded an ongoing investigation into Pharmacy Benefit Managers (PBMs) by requesting information about their use of foreign-based group purchasing organizations (GPOs). Letters sent to the Chief Executive Officers of The Cigna Group and Optum Rx seek documents regarding the PBMs’ overseas GPO operations.

“The Committee is investigating whether Cigna Group’s Evernorth Health Services, the parent company of Express Scripts, uses its foreign headquartered group purchasing organization (GPO)—Ascent Health Services, Inc. (Ascent) which is headquartered in Switzerland—to evade transparency and oversight in the United States. The Committee requests documents and communications regarding the creation and role of Ascent,” wrote Chairman Comer in a letter to The Cigna Group.

In July 2024, the House Oversight Committee released a report outlining how PBMs have influenced prescription drug markets through policies that can limit competition. The report noted that GPOs add complexity to pricing structures, especially when they are based outside the U.S., as these entities may be used to retain additional revenue streams and avoid domestic regulations. According to the committee, Emisar Pharma was established by UnitedHealth Group’s Optum Rx in 2021 with headquarters in Ireland, while Ascent was created by Cigna Group’s Express Scripts in 2019 and is based in Switzerland.

“The Committee is investigating whether UnitedHealth Group’s Optum Rx, uses its foreign headquartered group purchasing organization (GPO)—Emisar Pharma Services, LLC (Emisar Pharma) headquartered in Ireland—to evade transparency and oversight in the United States. The Committee requests documents and communications regarding the creation and role of Emisar Pharma,” wrote Chairman Comer in a letter to Optum Rx.

James Comer has represented Kentucky’s 1st district in Congress since 2016 after succeeding Ed Whitfield. Before his tenure in Congress, he served from 2001 to 2012 as a member of the Kentucky House of Representatives. Comer was born in Carthage, Tennessee, currently resides in Tompkinsville, Kentucky, and graduated from Western Kentucky University with a Bachelor of Science degree.

Letters were addressed to Mr. David Cordani, Chairman and CEO of The Cigna Group; and Dr. Patrick Conway, CEO of Optum Rx.



Related

Jim Jones Deputy Commissioner for Human Foods of FDA

How many companies were inspected by the FDA in cities located in Daviess County in September?

There was one company in a city associated with Daviess County that received an FDA inspection in September, according to the U.S. Food and Drug Administration.

James Comer U.S. House of Representatives from Kentucky's 1st district

House Oversight schedules markup on multiple bills targeting crime policy changes in Washington D.C

The House Committee on Oversight and Government Reform, chaired by James Comer (R-Ky.), has scheduled a full committee markup for September 10 to review several legislative proposals aimed at addressing crime in Washington, D.C. The session will…

James Comer U.S. House of Representatives from Kentucky's 1st district

Comer investigates alleged misuse of patient data by CVS Health for lobbying efforts

House Oversight Committee Chairman James Comer (R-Ky.) and Subcommittee on Federal Law Enforcement Chairman Clay Higgins (R-La.) have launched an investigation into CVS Health’s reported use of confidential patient information to lobby against…

Trending

The Weekly Newsletter

Sign-up for the Weekly Newsletter from NW Kentucky News.